Legit.ng on MSN
2026 JAMB registration update for UTME and DE applicants
Candidates for the Unified Tertiary Matriculation Examination (UTME) and Direct Entry (DE) are to obtain their ePIN through Interswitch-supported payment platforms.
Dozens of asylum cases filed by Somali migrants in immigration courts were suddenly rescheduled and recategorized over the weekend, according to four lawyers interviewed by NPR. NPR has learned that ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Damian Garde is a reporter at ...
House Democrats have informed GOP leaders they will not help pass a funding package through a fast-track process, a source familiar with the matter confirmed to The Hill — complicating Speaker Mike ...
Speaker Mike Johnson (R-La.) told House Republicans he wants to utilize a special fast-track process that will require cooperation from Democrats to swiftly pass the funding package that the Senate is ...
Drug Farm Announces FDA Fast Track Designation for First-in-Class ALPK1 Inhibitor DF-003 for the Treatment of ROSAH Syndrome Drug Farm, a clinical-stage biopharmaceutical company advancing two novel ...
A leader’s potential is often shaped by the choices they made long before they stepped into their role. The most effective leaders seek experiences that stretch their thinking, build influence and ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology for the treatment of early-stage ...
ROCHESTER, Minn.--(BUSINESS WIRE)--INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet ...
Shares of microcap biotech Invivyd (IVVD) moved higher in the premarket on Tuesday after the Waltham, Massachusetts-headquartered company announced the FDA’s Fast Track designation for its ...
Designation underscores the potential of SAFEbody®-enabled anti-CTLA-4 therapy to address unmet need in MSS colorectal cancer SAN DIEGO and SUZHOU, China, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Adagene Inc ...
The FDA's fast track designation for muzastotug with Keytruda targets microsatellite stable metastatic colorectal cancer without liver metastases, based on promising early clinical evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results